Use of natriuretic peptides in clinical decision-making for patients with non–ST-elevation acute coronary syndromes
Authors:
- James A. de LemosJLJames A. de Lemos
- 1 April 2007
- journal article
- editorial
- Published by Elsevier in American Heart Journal
- Vol. 153 (4) , 450-453
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Troponin-T and N-Terminal Pro-B-Type Natriuretic Peptide Predict Mortality Benefit From Coronary Revascularization in Acute Coronary SyndromesJACC, 2006
- Comparison of B-Type Natriuretic Peptides for Assessment of Cardiac Function and Prognosis in Stable Ischemic Heart DiseaseJACC, 2006
- Prognostic Value of Serial B-Type Natriuretic Peptide Testing During Follow-up of Patients With Unstable Coronary Artery DiseaseJAMA, 2005
- N-Terminal Pro–B-Type Natriuretic Peptide and Long-Term Mortality in Stable Coronary Heart DiseaseNew England Journal of Medicine, 2005
- N-Terminal Pro-Brain Natriuretic Peptide on Admission Has Prognostic Value Across the Whole Spectrum of Acute Coronary SyndromesCirculation, 2004
- Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST-elevation acute coronary syndromesEuropean Heart Journal, 2004
- N -Terminal Pro–Brain Natriuretic Peptide and Other Risk Markers for the Separate Prediction of Mortality and Subsequent Myocardial Infarction in Patients With Unstable Coronary Artery DiseaseCirculation, 2003
- Evaluation of B-type natriuretic peptide for risk assessment in unstable Angina/Non–ST-elevation myocardial infarctionJACC, 2003
- N-Terminal Pro-B–Type Natriuretic Peptide and Long-Term Mortality in Acute Coronary SyndromesCirculation, 2002
- The Prognostic Value of B-Type Natriuretic Peptide in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2001